Alpérovitch A - Search Results

1

Risk factors of multiple system atrophy: a case-control study in French patients.

Vidal JS, Vidailhet M, Elbaz A, Derkinderen P, Tzourio C, Alpérovitch A. Vidal JS, et al. Among authors: alperovitch a. Mov Disord. 2008 Apr 30;23(6):797-803. doi: 10.1002/mds.21857. Mov Disord. 2008. PMID: 18307243

2

S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship.

Elbaz A, Levecque C, Clavel J, Vidal JS, Richard F, Corrèze JR, Delemotte B, Amouyel P, Alpérovitch A, Chartier-Harlin MC, Tzourio C. Elbaz A, et al. Among authors: alperovitch a. Mov Disord. 2003 Feb;18(2):130-7. doi: 10.1002/mds.10326. Mov Disord. 2003. PMID: 12539205

3

Cigarette smoking and Parkinson's disease: a case-control study in a population characterized by a high prevalence of pesticide exposure.

Galanaud JP, Elbaz A, Clavel J, Vidal JS, Corrèze JR, Alpérovitch A, Tzourio C. Galanaud JP, et al. Among authors: alperovitch a. Mov Disord. 2005 Feb;20(2):181-9. doi: 10.1002/mds.20307. Mov Disord. 2005. PMID: 15468111

4

Risk factors for progressive supranuclear palsy: a case-control study in France.

Vidal JS, Vidailhet M, Derkinderen P, de Gaillarbois TD, Tzourio C, Alpérovitch A. Vidal JS, et al. Among authors: alperovitch a. J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1271-4. doi: 10.1136/jnnp.2008.149849. J Neurol Neurosurg Psychiatry. 2009. PMID: 19864660

5

Bias in association studies resulting from gene-environment interactions and competing risks.

Elbaz A, Alpérovitch A. Elbaz A, et al. Among authors: alperovitch a. Am J Epidemiol. 2002 Feb 1;155(3):265-72. doi: 10.1093/aje/155.3.265. Am J Epidemiol. 2002. PMID: 11821252

6

Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study.

Levecque C, Elbaz A, Clavel J, Richard F, Vidal JS, Amouyel P, Tzourio C, Alpérovitch A, Chartier-Harlin MC. Levecque C, et al. Among authors: alperovitch a. Hum Mol Genet. 2003 Jan 1;12(1):79-86. doi: 10.1093/hmg/ddg009. Hum Mol Genet. 2003. PMID: 12490535

7

CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.

Elbaz A, Levecque C, Clavel J, Vidal JS, Richard F, Amouyel P, Alpérovitch A, Chartier-Harlin MC, Tzourio C. Elbaz A, et al. Among authors: alperovitch a. Ann Neurol. 2004 Mar;55(3):430-4. doi: 10.1002/ana.20051. Ann Neurol. 2004. PMID: 14991823

8

Memantine therapy for Alzheimer disease in real-world practice: an observational study in a large representative sample of French patients.

Vidal JS, Lacombe JM, Dartigues JF, Pasquier F, Robert P, Tzourio C, Alpérovitch A. Vidal JS, et al. Among authors: alperovitch a. Alzheimer Dis Assoc Disord. 2008 Apr-Jun;22(2):125-30. doi: 10.1097/WAD.0b013e31815a9e10. Alzheimer Dis Assoc Disord. 2008. PMID: 18525283

9

Evaluation of the impact of memantine treatment initiation on psychotropics use: a study from the French national health care database.

Vidal JS, Lacombe JM, Dartigues JF, Pasquier F, Robert P, Tzourio C, Alpérovitch A. Vidal JS, et al. Among authors: alperovitch a. Neuroepidemiology. 2008;31(3):193-200. doi: 10.1159/000158226. Epub 2008 Sep 25. Neuroepidemiology. 2008. PMID: 18815451

10

Professional exposure to pesticides and Parkinson disease.

Elbaz A, Clavel J, Rathouz PJ, Moisan F, Galanaud JP, Delemotte B, Alpérovitch A, Tzourio C. Elbaz A, et al. Among authors: alperovitch a. Ann Neurol. 2009 Oct;66(4):494-504. doi: 10.1002/ana.21717. Ann Neurol. 2009. PMID: 19847896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters